A Phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The OUTBACK trial [ 2013 - 2018 ]

Also known as: The OUTBACK trial - the role of adjuvant chemotherapy in locally advanced cervical cancer

Research Grant

[Cite as]

Researchers: A/Pr Linda Mileshkin (Principal investigator) ,  A/Pr Kailash Narayan A/Pr Kathleen Moore Dr Julie Martyn Prof Danny Rischin
View all 10 related researchers

Brief description This international randomized phase III trial will test the value of giving additional chemotherapy treatment to women with locally advanced cervix cancer following standard chemo-radiation treatment. The aim is to improve survival rates for these women, many of whom have a 40% or greater chance of their disease relapsing after treatment. The trial has been designed in Australia, and is open in multiple countries with Australia New Zealand Gynaecological Oncology Group (ANZGOG) as the lead group.

Funding Amount $AUD 1,540,681.73

Funding Scheme Project Grants

Notes Standard Project Grant

Viewed: [[ro.stat.viewed]]